What are the risks of COVID-19 infection in pregnant women?

Since December, 2019, the outbreak of the 2019 novel coronavirus disease (COVID-19) infection has become a major epidemic threat in China. Soe Zeya Tun/Reuters Previous studies have shown that SARS during pregnancy is associated with a high incidence of adverse maternal and neonatal complications, s...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 395; no. 10226; pp. 760 - 762
Main Author Qiao, Jie
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 07.03.2020
Elsevier Limited
Subjects
Babies
Betacoronavirus
Comment
Coronavirus Infections
Coronaviruses
COVID-19
Disease control
Disease prevention
Disease transmission
Epidemics
Female
Humans
Infections
Infectious Disease Transmission, Vertical
Infectious diseases
Intubation
Medical Records
Neonates
Newborn babies
Pandemics
Pathogens
Pneumonia
Pneumonia, Viral
Pregnancy
Pregnancy complications
Pregnancy Complications, Infectious
Renal failure
Respiratory diseases
Retrospective Studies
SARS-CoV-2
Severe acute respiratory syndrome
Viral diseases
Womens health
Middle East
China
Online AccessGet full text

Cover

More Information
Summary:Since December, 2019, the outbreak of the 2019 novel coronavirus disease (COVID-19) infection has become a major epidemic threat in China. Soe Zeya Tun/Reuters Previous studies have shown that SARS during pregnancy is associated with a high incidence of adverse maternal and neonatal complications, such as spontaneous miscarriage, preterm delivery, intrauterine growth restriction, application of endotracheal intubation, admission to the intensive care unit, renal failure, and disseminated intravascular coagulopathy.9,11 However, pregnant women with COVID-19 infection in the present study had fewer adverse maternal and neonatal complications and outcomes than would be anticipated for those with SARS-CoV-1 infection. [...]pregnant women and newborn babies should be considered key at-risk populations in strategies focusing on prevention and management of COVID-19 infection.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
ISSN:0140-6736
1474-547X
1474-547X
DOI:10.1016/S0140-6736(20)30365-2